Welcome to our dedicated page for Baxter Intl news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter Intl stock.
Baxter International Inc. reports news on its global medtech business, which supplies hospitals, physician offices and other care settings with connected solutions, medical devices and advanced injectable technologies. Company updates commonly cover results from continuing operations following the Kidney Care divestiture, portfolio activity in infusion therapies and platforms, surgical tables, smart stretchers, patient-support systems, monitoring tools, and hemostatic and sealing agents.
Baxter announcements also address product introductions such as the IV Verify Line Labeling System, conference showcases for Global Surgical Solutions, Advanced Surgery and Patient Support Systems, annual-meeting matters, executive finance leadership, and foundation partnerships tied to healthcare settings.
Baxter International (NYSE:BAX) has received FDA 510(k) clearance for its new Novum IQ syringe infusion pump, which features Dose IQ Safety Software. This advancement aims to enhance medication delivery safety, specifically for neonatal and pediatric patients. The Novum IQ SYR integrates seamlessly with hospital electronic medical records (EMRs) and incorporates advanced safety measures, including drug library access and titration error prevention. Baxter's IQ Enterprise Connectivity Suite allows for real-time infusion data and operating system upgrades, optimizing hospital resources.
Baxter International Inc. (NYSE:BAX) will present at the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 10:25 a.m. Eastern Time. CFO Jay Saccaro is scheduled to discuss the company’s innovations and healthcare solutions. A live webcast of the presentation can be accessed at www.baxter.com and will be available for replay until February 23, 2023. Baxter has a 90-year history of providing critical healthcare products and services globally, impacting millions of patients and caregivers.
Baxter International Inc. (NYSE:BAX) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022. Jay Saccaro, Chief Financial Officer, is set to present at 10:35 a.m. Eastern Time. A live webcast of the presentation will be available on Baxter's website and can be replayed until March 13, 2023. Baxter has a long-standing history of providing essential medical products and innovations that improve healthcare across more than 100 countries.
Summary not available.
Baxter International Inc. (NYSE:BAX) reported second-quarter 2022 revenue of $3.75 billion, marking a 21% increase on a reported basis and a 26% increase on a constant currency basis. U.S. GAAP EPS was $0.50, with adjusted EPS at $0.87. The company anticipates full-year sales growth in the high teens and forecasts U.S. GAAP EPS between $1.82 and $1.92. Despite operational challenges, including supply chain issues, Baxter's acquisition of Hillrom contributed significantly to performance, generating $715 million in sales.
Baxter International Inc. (NYSE:BAX) has declared a quarterly cash dividend of $0.29 per share, payable on October 3, 2022, to shareholders on record as of September 2, 2022. This brings the indicated annual dividend rate to $1.16 per share. Baxter, a leader in medical technology, provides critical care and innovative healthcare solutions globally, with a mission to save and sustain lives. The company emphasizes its commitment to shareholder value through consistent dividend payments, though future payouts may vary based on financial conditions.
Summary not available.
Baxter International Inc. (NYSE:BAX) will host a conference call on July 28, 2022, at 7:30 a.m. CT to discuss its second-quarter financial results. Interested participants can join the call via a pre-registration link or through Baxter's website. The call will be recorded and is copyrighted material.
Baxter has been a leader in medtech for 90 years, providing essential products and solutions across various care settings globally, impacting millions of patients and caregivers daily. For more information, visit www.baxter.com.
Baxter International Inc. (NYSE:BAX) is set to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 10:40 a.m. Pacific Time. José Almeida, the company’s CEO, will lead the presentation. The event will feature a live webcast, accessible at www.baxter.com, with replay available until June 13, 2023. Baxter continues to deliver critical healthcare solutions globally, enhancing patient care for nearly a century.
Baxter International (NYSE:BAX) hosted its 2022 Investor Conference, outlining its strategy for growth and innovation following the Dec. 2021 acquisition of Hillrom. The company aims to enhance patient care and operational efficiency, expecting constant currency sales growth of 4-5% from 2022-2025, with a projected adjusted operating margin increase of 350-400 basis points by 2025. Baxter anticipates $350 million in annual cost synergies and $200 million in revenue synergies by 2025 from the acquisition. Innovations showcased include the Sharesource platform and Voalte communication technologies.